Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fluorescent leukotriene B4: potential applications.

Alan Sabirsh1, Anders Wetterholm, Jesper Bristulf

  • 1Department of Medical Biochemistry and Biophysics, Division of Physiological Chemistry II, Karolinska Institute, Stockholm, Sweden. alan.sabirsh@mbb.ki.se

Journal of Lipid Research
|April 5, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Orally Available Halothiazole Glycomimetic as a Cancer-Targeting Dual Galectin-1 and Galectin-3 Inhibitor.

Journal of medicinal chemistry·2026
Same author

Galectin-8 binds HIV envelope glycoproteins with high affinity and promotes viral infectivity.

Frontiers in cellular and infection microbiology·2026
Same author

The Impact of Polyethylene Glycol Lipid Anchors on the Physicochemical Properties, Protein Corona, Function, and Biodistribution of Lipid Nanoparticles.

ACS nano·2026
Same author

Synthesis of β-d-C-galactopyranosyl compounds including constrained derivatives from clickable building blocks and evaluation as ligands for galectins.

European journal of medicinal chemistry·2026
Same author

LTB4 Activates the MAP Kinase Pathway in Endothelial Cells to Cause Long-Lasting Neutrophil Tethering, MCP-1 and NO Releases.

Scandinavian journal of immunology·2026
Same author

Animal models in leukotriene research: Current insights into complex pathways and therapeutic intervention.

Pharmacology & therapeutics·2025

Researchers developed fluorescent Leukotriene B4 (LTB4) analogs for studying inflammation. These novel probes offer a cost-effective and versatile alternative to radioligands for analyzing LTB4 receptor interactions.

Area of Science:

  • Biochemistry
  • Immunology
  • Molecular Biology

Background:

  • Leukotriene B4 (LTB4) is a key lipid mediator in inflammatory processes.
  • LTB4 exerts its effects through the G-protein-coupled receptor BLT1.
  • Current methods for studying LTB4-BLT1 interactions often rely on radioligands, which have associated disadvantages.

Purpose of the Study:

  • To synthesize and characterize novel fluorescent analogs of LTB4.
  • To evaluate the utility of these fluorescent analogs as tools for studying LTB4 receptor binding and activation.
  • To provide a cost-effective and user-friendly alternative to radiolabeled LTB4.

Main Methods:

  • Synthesis and characterization of fluorescent LTB4 analogs.
  • Functional assays to determine agonist activity (EC50 values) of fluorescent LTB4.

Related Experiment Videos

  • Confocal imaging and flow cytometry to assess colocalization with BLT1.
  • Fluorescence polarization assays to measure binding affinity (Kd) and competitive displacement.
  • Fluorescence resonance energy transfer (FRET) to observe binding interactions.

    • Main Results:

    • Fluorescent LTB4 analogs were successfully synthesized and found to be full agonists of BLT1.
    • Orange and green fluorescent LTB4 activated BLT1 with EC50 values of 68 nM and 40 nM, respectively.
    • Fluorescent LTB4 colocalized with BLT1 in cellular assays.
    • Orange fluorescent LTB4 demonstrated specific binding to BLT1 with a Kd of 66 nM, displaceable by LTB4 and BLT1 ligands.
    • Fluorescent LTB4 analogs could displace tritiated LTB4 and were detectable via FRET.

    Conclusions:

    • Fluorescent LTB4 analogs represent a valuable, inexpensive, and easy-to-produce alternative to radiolabeled LTB4.
    • These fluorescent probes facilitate the study of LTB4 receptor interactions using various detection technologies, including high-throughput screening.
    • The developed fluorescent LTB4 analogs are effective for labeling BLT1 receptors and enable detailed analysis of ligand-receptor dynamics.